Applied Genetic Technologies (AGTC) Reports Q2 EPS of 17c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Wall St eyes best day in a month as Anthropic's IPO filing propels AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
Tweet
Share
E-mailGet Alerts AGTC Hot Sheet
Join SI Premium – FREE
Applied Genetic Technologies (NASDAQ: AGTC) reported Q2 EPS of $0.17, may not compare to the analyst estimate of ($0.19). Revenue for the quarter came in at $12.2 million versus the consensus estimate of $8.76 million.
For earnings history and earnings-related data on Applied Genetic Technologies (AGTC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Can JetBlue still avoid bankruptcy? Analysis says yes, but it won’t be easy
- CIBC Starts Telesat Corp (TSAT) at Outperformer, 'Clearing The Way For Lightspeed'
- Wells Fargo Highlights Top Shopping Center REITs Ahead of Q3 Earnings
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
